Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West

FDA inspection history in Shizuishan, China, 2018 to 2019

3
Form 483s

Every document, by year

  • Form 483

2018: one amended 483 and one Form 483; 2019: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018–19Two Form 483s and one amended 483, at Shizuishan, China.
  2. 2018The longest 483 on file: 12 observations over 9 pages at Shizuishan, China.

Cited most

Across all Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West observations on file

The complete Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2019-12-06483 Form 483$99
2018-10-19Amended 483 Amended 483$99
2018-10-15483 Form 483$99

FEI number 3012375554 · most recent document Dec 6, 2019

About Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West

How many FDA Form 483s has Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West received?

FDA Intel has 3 Form 483s on file for Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West; the most recent is dated Dec 6, 2019.

When was Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West last inspected by FDA?

The most recent FDA inspection document on file for Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West is a Form 483 dated Dec 6, 2019, for the site in Shizuishan, China.

What did FDA cite at Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West?

The regulations cited most in the observations on file for Livzon Group (Ningxia) Pharmaceutical Co., Ltd. Toushi Road West are 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.67 (Equipment cleaning and maintenance), 2 times; 21 CFR 211.125 (Labeling issuance), 1 time.